CBD
2022-06-07: reference:
CBD #
-
Cannabidiol Elevates Mechanistic Target of Rapamycin Inhibitor Levels in Patients With Tuberous Sclerosis Complex #
- May even be an antagonist of CB1/CB2.
- CB2 inverse agonist?
- A2A agonist
- 5-HT1A partial agonist/PAM, and inverse agonist at high doses.
- μ-Opioid Receptor and δ-Opioid Receptor PAM. PPAR-γ agonism?
Supplementation #
~6% oral bioavailability and 11-45% via inhalation.